Interleukin-1 Receptor Antagonist: a Promising Cytokine Against Human Squamous Cell Carcinomas

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Apr 7

PMID 37025835

Authors

Yujie Ding

Jie Yi

Jinxin Wang

Zhida Sun

Affiliations

Soon will be listed here.

Abstract

Inflammation, especially chronic inflammation, is closely linked to tumor development. As essential chronic inflammatory cytokines, the interleukin family plays a key role in inflammatory infections and malignancies. The interleukin-1 (IL-1) receptor antagonist (IL1RA), as a naturally occurring receptor antagonist, is the first discovered and can compete with IL-1 in binding to the receptor. Recent studies have revealed the association of the polymorphisms in IL1RA with an increased risk of squamous cell carcinomas (SCCs), including squamous cell carcinoma of the head and neck (SCCHN), cervical squamous cell carcinoma, cutaneous squamous cell carcinoma (cSCC), esophageal squamous cell carcinoma (ESCC), and bronchus squamous cell carcinoma. Here, we reviewed the antitumor potential of IL1RA as an IL-1-targeted inhibitor.

Citing Articles

Association of Variants in (rs2234663) and (rs1143627, rs16944) and Interleukin-1β Levels with Colorectal Cancer: Experimental Study and In Silico Analysis.

Gallegos-Arreola M, Garibaldi-Rios A, Gutierrez-Hurtado I, Zuniga-Gonzalez G, Figuera L, Gomez-Meda B Genes (Basel). 2025; 15(12.

PMID: 39766795 PMC: 11675222. DOI: 10.3390/genes15121528.

IL-1 receptor antagonist: etiological and drug delivery systems overview.

Ubhe A Inflamm Res. 2024; 73(12):2231-2247.

PMID: 39455436 DOI: 10.1007/s00011-024-01960-y.

Unraveling the immune landscape of lung adenocarcinoma: insights for tailoring therapeutic approaches.

Wu C, Qin W, Lu W, Lin J, Yang H, Li C Discov Oncol. 2024; 15(1):470.

PMID: 39331252 PMC: 11436577. DOI: 10.1007/s12672-024-01396-0.

Inflammation and endothelial function relevant genetic polymorphisms, carotid atherosclerosis, and vascular events in high-risk stroke population.

Chen H, Qing T, Luo H, Yu M, Wang Y, Wei W Front Neurol. 2024; 15:1405183.

PMID: 38827573 PMC: 11144032. DOI: 10.3389/fneur.2024.1405183.

Selective Upregulation of Interleukin 1 Receptor Antagonist and Interleukin-8 in Fuchs' Endothelial Corneal Dystrophy with Accompanying Cataract.

Fiolka R, Wylegala E, Toborek M, Adamczyk-Zostawa J, Czuba Z, Wylegala A J Clin Med. 2024; 13(10).

PMID: 38792359 PMC: 11121793. DOI: 10.3390/jcm13102815.

References

Tountas N, Yang H, Di Giovine F, Vecchi M, Kam L, Melani L . Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999; 117(4):806-13. DOI: 10.1016/s0016-5085(99)70338-0. View

Dinarello C . Interleukin-1 and interleukin-1 antagonism. Blood. 1991; 77(8):1627-52. View

Bar D, Apte R, Voronov E, Dinarello C, Cohen S . A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J. 2003; 18(1):161-3. DOI: 10.1096/fj.03-0483fje. View

Steinkasserer A, Spurr N, Cox S, Jeggo P, Sim R . The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992; 13(3):654-7. DOI: 10.1016/0888-7543(92)90137-h. View

Tan Q, Huang Q, Ma Y, Mao K, Yang G, Luo P . Potential roles of IL-1 subfamily members in glycolysis in disease. Cytokine Growth Factor Rev. 2018; 44:18-27. DOI: 10.1016/j.cytogfr.2018.11.001. View

Hamajima N, Takezaki T, Tajima K . Allele Frequencies of 25 Polymorphisms Pertaining to Cancer Risk for Japanese, Koreans and Chinese. Asian Pac J Cancer Prev. 2003; 3(3):197-206. View

Alvarez A, Asumendi A, Urcelay B, Tonino P, Dinarello C . Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst. 1996; 88(3-4):198-205. DOI: 10.1093/jnci/88.3-4.198. View

Romano A, Conway T . Evolution of carbohydrate metabolic pathways. Res Microbiol. 1996; 147(6-7):448-55. DOI: 10.1016/0923-2508(96)83998-2. View

Rider P, Carmi Y, Yossef R, Guttman O, Eini H, Azam T . IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. J Immunol. 2015; 195(4):1705-12. DOI: 10.4049/jimmunol.1501168. View

10.

Bose S, Le A . Glucose Metabolism in Cancer. Adv Exp Med Biol. 2018; 1063:3-12. DOI: 10.1007/978-3-319-77736-8_1. View

11.

Voronov E, Carmi Y, Apte R . The role IL-1 in tumor-mediated angiogenesis. Front Physiol. 2014; 5:114. PMC: 3975103. DOI: 10.3389/fphys.2014.00114. View

12.

Huang C, Yang G, Jiang T, Zhu G, Li H, Qiu Z . The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma. 2011; 58(5):396-405. DOI: 10.4149/neo_2011_05_396. View

13.

Zhang Y, Liu C, Peng H, Zhang J, Feng Q . IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis. PLoS One. 2012; 7(9):e46017. PMC: 3457944. DOI: 10.1371/journal.pone.0046017. View

14.

Eizirik D, Tracey D, Bendtzen K, Sandler S . An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia. 1991; 34(6):445-8. DOI: 10.1007/BF00403185. View

15.

Sanchez-Danes A, Blanpain C . Deciphering the cells of origin of squamous cell carcinomas. Nat Rev Cancer. 2018; 18(9):549-561. PMC: 7170720. DOI: 10.1038/s41568-018-0024-5. View

16.

ONeill L . How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol. 2005; 18(1):3-9. DOI: 10.1016/j.coi.2005.11.012. View

17.

Arend W . Interleukin-1 receptor antagonist. Adv Immunol. 1993; 54:167-227. DOI: 10.1016/s0065-2776(08)60535-0. View

18.

Keeley B, Islami F, Pourshams A, Poustchi H, Pak J, Brennan P . Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Cancer Sci. 2014; 105(9):1205-11. PMC: 4304770. DOI: 10.1111/cas.12485. View

19.

Kushwah A, Gupta M, Singh R, Banerjee M . Cytokine gene variants and treatment outcome of cisplatin-based concomitant chemoradiotherapy in cervical cancer. Br J Biomed Sci. 2020; 77(2):81-86. DOI: 10.1080/09674845.2020.1714164. View

20.

Hurme M, Santtila S . IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998; 28(8):2598-602. DOI: 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K. View